Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging

Diana Vivian, Kunrong Cheng, Sandeep Khurana, Su Xu, Paul A. Dawson, Jean Pierre Raufman, James E. Polli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Previously, we developed a trifluorinated bile acid, CA-lys-TFA, with the objective of noninvasively assessing bile acid transport in vivo using 19F magnetic resonance imaging (MRI). CA-lys-TFA was successfully imaged in the mouse gallbladder, but was susceptible to deconjugation in vitro by choloylglycine hydrolase (CGH), a bacterial bile acid deconjugating enzyme found in the terminal ileum and colon. The objective of the present study was to develop a novel trifluorinated bile acid resistant to deconjugation by CGH. CA-sar-TFMA was designed, synthesized, and tested for in vitro transport properties, stability, imaging properties, and its ability to differentially accumulate in the gallbladders of normal mice, compared with mice with known impaired bile acid transport (deficient in the apical sodium-dependent bile acid transporter, ASBT). CA-sar-TFMA was a potent inhibitor and substrate of ASBT and the Na+/taurocholate cotransporting polypeptide. Stability was favorable in all conditions tested, including the presence of CGH. CA-sar-TFMA was successfully imaged and accumulated at 16.1-fold higher concentrations in gallbladders from wild-type mice compared with those from Asbt-deficient mice. Our results support the potential of using MRI with CA-sar-TFMA as a noninvasive method to assess bile acid transport in vivo.

Original languageEnglish (US)
Pages (from-to)3782-3792
Number of pages11
JournalJournal of Pharmaceutical Sciences
Volume103
Issue number11
DOIs
StatePublished - Nov 2014

Fingerprint

Fluorine
choloylglycine hydrolase
Bile Acids and Salts
Magnetic Resonance Imaging
Gallbladder
Taurocholic Acid
Ileum
Colon
Peptides
Enzymes

Keywords

  • Bile acid malabsorption
  • Bile acid transporters
  • Biliary excretion
  • Enterohepatic circulation
  • Fluorine MRI
  • Imaging methods
  • Intestinal absorption
  • Site-specific delivery
  • Targeted drug delivery
  • Transporters

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. / Vivian, Diana; Cheng, Kunrong; Khurana, Sandeep; Xu, Su; Dawson, Paul A.; Raufman, Jean Pierre; Polli, James E.

In: Journal of Pharmaceutical Sciences, Vol. 103, No. 11, 11.2014, p. 3782-3792.

Research output: Contribution to journalArticle

Vivian, Diana ; Cheng, Kunrong ; Khurana, Sandeep ; Xu, Su ; Dawson, Paul A. ; Raufman, Jean Pierre ; Polli, James E. / Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. In: Journal of Pharmaceutical Sciences. 2014 ; Vol. 103, No. 11. pp. 3782-3792.
@article{8ebcd538c93d4fddaaa84b6473092783,
title = "Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging",
abstract = "Previously, we developed a trifluorinated bile acid, CA-lys-TFA, with the objective of noninvasively assessing bile acid transport in vivo using 19F magnetic resonance imaging (MRI). CA-lys-TFA was successfully imaged in the mouse gallbladder, but was susceptible to deconjugation in vitro by choloylglycine hydrolase (CGH), a bacterial bile acid deconjugating enzyme found in the terminal ileum and colon. The objective of the present study was to develop a novel trifluorinated bile acid resistant to deconjugation by CGH. CA-sar-TFMA was designed, synthesized, and tested for in vitro transport properties, stability, imaging properties, and its ability to differentially accumulate in the gallbladders of normal mice, compared with mice with known impaired bile acid transport (deficient in the apical sodium-dependent bile acid transporter, ASBT). CA-sar-TFMA was a potent inhibitor and substrate of ASBT and the Na+/taurocholate cotransporting polypeptide. Stability was favorable in all conditions tested, including the presence of CGH. CA-sar-TFMA was successfully imaged and accumulated at 16.1-fold higher concentrations in gallbladders from wild-type mice compared with those from Asbt-deficient mice. Our results support the potential of using MRI with CA-sar-TFMA as a noninvasive method to assess bile acid transport in vivo.",
keywords = "Bile acid malabsorption, Bile acid transporters, Biliary excretion, Enterohepatic circulation, Fluorine MRI, Imaging methods, Intestinal absorption, Site-specific delivery, Targeted drug delivery, Transporters",
author = "Diana Vivian and Kunrong Cheng and Sandeep Khurana and Su Xu and Dawson, {Paul A.} and Raufman, {Jean Pierre} and Polli, {James E.}",
year = "2014",
month = "11",
doi = "10.1002/jps.24131",
language = "English (US)",
volume = "103",
pages = "3782--3792",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging

AU - Vivian, Diana

AU - Cheng, Kunrong

AU - Khurana, Sandeep

AU - Xu, Su

AU - Dawson, Paul A.

AU - Raufman, Jean Pierre

AU - Polli, James E.

PY - 2014/11

Y1 - 2014/11

N2 - Previously, we developed a trifluorinated bile acid, CA-lys-TFA, with the objective of noninvasively assessing bile acid transport in vivo using 19F magnetic resonance imaging (MRI). CA-lys-TFA was successfully imaged in the mouse gallbladder, but was susceptible to deconjugation in vitro by choloylglycine hydrolase (CGH), a bacterial bile acid deconjugating enzyme found in the terminal ileum and colon. The objective of the present study was to develop a novel trifluorinated bile acid resistant to deconjugation by CGH. CA-sar-TFMA was designed, synthesized, and tested for in vitro transport properties, stability, imaging properties, and its ability to differentially accumulate in the gallbladders of normal mice, compared with mice with known impaired bile acid transport (deficient in the apical sodium-dependent bile acid transporter, ASBT). CA-sar-TFMA was a potent inhibitor and substrate of ASBT and the Na+/taurocholate cotransporting polypeptide. Stability was favorable in all conditions tested, including the presence of CGH. CA-sar-TFMA was successfully imaged and accumulated at 16.1-fold higher concentrations in gallbladders from wild-type mice compared with those from Asbt-deficient mice. Our results support the potential of using MRI with CA-sar-TFMA as a noninvasive method to assess bile acid transport in vivo.

AB - Previously, we developed a trifluorinated bile acid, CA-lys-TFA, with the objective of noninvasively assessing bile acid transport in vivo using 19F magnetic resonance imaging (MRI). CA-lys-TFA was successfully imaged in the mouse gallbladder, but was susceptible to deconjugation in vitro by choloylglycine hydrolase (CGH), a bacterial bile acid deconjugating enzyme found in the terminal ileum and colon. The objective of the present study was to develop a novel trifluorinated bile acid resistant to deconjugation by CGH. CA-sar-TFMA was designed, synthesized, and tested for in vitro transport properties, stability, imaging properties, and its ability to differentially accumulate in the gallbladders of normal mice, compared with mice with known impaired bile acid transport (deficient in the apical sodium-dependent bile acid transporter, ASBT). CA-sar-TFMA was a potent inhibitor and substrate of ASBT and the Na+/taurocholate cotransporting polypeptide. Stability was favorable in all conditions tested, including the presence of CGH. CA-sar-TFMA was successfully imaged and accumulated at 16.1-fold higher concentrations in gallbladders from wild-type mice compared with those from Asbt-deficient mice. Our results support the potential of using MRI with CA-sar-TFMA as a noninvasive method to assess bile acid transport in vivo.

KW - Bile acid malabsorption

KW - Bile acid transporters

KW - Biliary excretion

KW - Enterohepatic circulation

KW - Fluorine MRI

KW - Imaging methods

KW - Intestinal absorption

KW - Site-specific delivery

KW - Targeted drug delivery

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=84914818339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914818339&partnerID=8YFLogxK

U2 - 10.1002/jps.24131

DO - 10.1002/jps.24131

M3 - Article

C2 - 25196788

AN - SCOPUS:84914818339

VL - 103

SP - 3782

EP - 3792

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 11

ER -